Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration

Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration

Abstract Age-related macular degeneration (AMD) is a progressive chronic disease causing visual impairment or central vision loss in the elderly. We hypothesized that successful rheopheresis would be associated with positive changes in soluble endoglin (sENG), PSCK9, alpha-2-macroglobulin (A2M), and...

Full description

Bibliographic Details
Main Authors: Vladimir Blaha, Jana Urbankova Rathouska, Hana Langrova, Milan Blaha, Jan Studnicka, Ctirad Andrys, Veronika Loefflerova, Miriam Lanska, Eva Vejrazkova, Petr Nachtigal, Alexandr Stepanov
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Age-related macular degeneration
Rheopheresis
Soluble endoglin
Alpha-2-macroglobulin
Online Access:https://doi.org/10.1038/s41598-024-80375-5

Internet

https://doi.org/10.1038/s41598-024-80375-5

Similar Items